170447 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans; Hormones Endothelin, vasoactive intestinal contractor [VIC]
ENDOTHELIN RECEPTOR ANTAGONISTS FOR USE IN TREATING OR PREVENTING MUSCLE FIBROSIS
#2METHOD AND COMPOSITIONS FOR THE TREATMENT AND DETECTION OF ENDOTHELIN-1 RELATED KIDNEY DISEASES
#3METHOD AND COMPOSITIONS FOR THE TREATMENT AND DETECTION OF ENDOTHELIN-1 RELATED KIDNEY DISEASES
#4Biomarkers for the diagnosis of invasive fungal infections
#5Method and compositions for the treatment and detection of endothelin-1 related kidney diseases
#6Method and compositions for the treatment and detection of endothelin-1 related kidney diseases
#7PROTECTION OF TCR SIGNALING CHAINS IN CANCER PATIENTS AND ENHANCEMENT OF CAR-T CELL THERAPY
#8DIAGNOSIS AND RISK STRATIFICATION USING NT-proET-1
#9USE OF BUFODIENOLIDES IN DIAGNOSING AND TREATING ESSENTIAL HYPERTENSION
#10Methods and compositions for assessing lung grafts
#11METHOD AND COMPOSITIONS FOR THE TREATMENT AND DETECTION OF ENDOTHELIN-1 RELATED KIDNEY DISEASES
#12Cancer treatment with endothelin receptor antagonists
#13Method and compositions for the treatment and detection of endothelin-1 related kidney diseases
#14Systems and methods for setting parameters of implantable medical devices using predictive marker data
#15METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#16Method for the determination of the formation of endothelins for medical diagnostic purposes, and antibodies and kits for carrying out such a method
#17Cancer treatment with endothelin receptor antagonists
#18Vasoactive hormone-based stratification of patients suffering from diseases related to endothelial function/dysfunction
#19Detection of bacterial infections in subjects suffering from dyspnea
#20Method and compositions for the treatment and detection of endothelin-1 related kidney diseases
#21PRO-ENDOTHELIN-1 FOR THE PREDICTION OF IMPAIRED PEAK OXYGEN CONSUMPTION
#22PRO-ENDOTHELIN-1 LEVELS FOR THE PREDICTION OF RISK OF TACHYARRHYTMIC EVENTS
#23Diagnosis and risk stratification using NT-proET-1
#24Method for diagnosis of a disease involving an anti-endothelin-receptor antibody
#25Cancer treatment with endothelin receptor antagonists
#26Method for controlling the therapy of patients suffering from cardiac insufficiency by means of in vitro determination of threshold values of vasoactive peptides
#27Methods for the diagnosis and treatment of critically ill patients with endothelin, endothelin agonists and adrenomedullin antagonists
#28Cellular antagonists of GPCR physiology
#29Method for the determination of the formation of endothelins for medical diagnostic purposes, and antibodies and kits for carrying out such a method
#30Prognostic Methods for Congestive Heart Failure
#31Drug screens based on the newly found role of dystroglycan proteolysis and restoration of dystroglycan function thereof
#32Method for screening for endothelin-receptor antagonist activity and for treating conditions caused by endothelin